Outcomes in Cardiac Transthyretin Amyloidosis and Association With New York Heart Association Class: Real-World Data.
Maximilian Leo MüllerEkaterina LatinovaKarl StanglIsabel MattigSebastian SpethmannDaniel R MessroghliKatrin HahnUlf LandmesserBettina HeideckerPublished in: Journal of the American Heart Association (2024)
Treatment of ATTR-CA with tafamidis led to substantial improvements of clinical outcome. NYHA classification at treatment initiation is a reliable tool to provide patients with individualized prognostic information.